RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1873 (1) , 188337
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War
This publication has 65 references indexed in Scilit:
- Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosisCancer Letters, 2009
- Targeting Protein Serine/Threonine Phosphatases for Drug DevelopmentMolecular Pharmacology, 2009
- Regression of prostate cancer xenografts by RLIP76 depletionBiochemical Pharmacology, 2009
- RLIP76: A novel glutathione-conjugate and multi-drug transporterBiochemical Pharmacology, 2009
- RLIP76 in Defense of Radiation PoisoningInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76FEBS Letters, 2008
- Bovine Papillomavirus Type 1: from Clathrin to CaveolinJournal of Virology, 2008
- Hsf-1 and POB1 Induce Drug Sensitivity and Apoptosis by Inhibiting Ralbp1Journal of Biological Chemistry, 2008
- Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76)Biochemical and Biophysical Research Communications, 2007
- Mitogenic and drug-resistance mediating effects of PKCα require RLIP76Biochemical and Biophysical Research Communications, 2006